A norovirus outbreak has been reported on a cruise ship, with more than 200 passengers sickened. Here's what to know about ...
Researchers have identified antibodies that could lead to a broadly protective norovirus vaccine and new treatment options.
A norovirus outbreak aboard a luxury cruise ship has left over 224 passengers and 17 crew members sickened, according to the ...
On January 8, 2025, Cocrystal Pharma, Inc. (NASDAQ:COCP) announced results from the Phase 1 trial of CDI-988 for the prophylaxis and treatment of norovirus, coronavirus, and other viral infections.
Norovirus affects the stomach and is hard to cure. Other symptoms include headache, fever and body aches. Symptoms begin 12 ...
The finding could lead to the design of broadly effective norovirus vaccine, as well as the development of new therapeutic antibodies for the treatment of norovirus-associated gastroenteritis.
Passengers and crew traveling on the Queen Mary 2 from England to the Caribbean reported symptoms of diarrhea and vomiting.
Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the 12 months ended December 31, 2024, and provides updates on its antiviral product pipeline, ...
The finding could lead to the design of broadly effective norovirus vaccine, as well as the development of new therapeutic antibodies for the treatment of norovirus-associated gastroenteritis.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback